Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,836 public trials 1,783 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients

NCT00128856

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Hospital Universitario Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
  • Hospital Universitario Fundación Alcorcón Alcorcón, Madrid, Spain
  • Complejo Hospitalario Unviesitario A Coruña A Coruña, Spain
View Trial Details
Completed

Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer

NCT00129922

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Hospital Universitario Virgen de los Lirios Alcoy, Alicante, Spain
  • Hospital General Universitario de Elche Elche, Alicante, Spain
  • Hospital General Universitario de Elda Elda, Alicante, Spain
  • Hospital Municipal de Badalona Badalona, Barcelona, Spain
View all 64 locations
View Trial Details
Completed

Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients

NCT00128843

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Germans Trias i Pujol Badalona, Barcelona, Spain
  • Clínico Universitario A Coruña (CHUAC) A Coruña, Galicia, Spain
  • Onkologikoa Donostia / San Sebastian, Guipúzcoa, Spain
  • Hospital Donostia Donostia / San Sebastian, Guipúzcoa, Spain
View all 13 locations
View Trial Details
Completed

Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis

NCT03847220

Conditions
Breast Carcinoma Metastatic to the Bone, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Hospital Universitario Virgen Del Rocío Seville, Andalusia, Spain
  • Hospital General de Guadalajara Guadalajara, Castille-La Mancha, Spain
  • ICO Badalona Hospital Universitari Germans Trias I Pujol Badalona, Catalonia, Spain
  • Hospital Universitari Clinic I Provincial Barcelona, Catalonia, Spain
View all 15 locations
View Trial Details
Completed

Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients

NCT00129896

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Hospital Universitario Virgen de los Lirios Alcoy, Alicante, Spain
  • Hospital Universitario Germans Trias i Pujol Badalona, Barcelona, Spain
  • Althaia-Xarxa Assistencial de Manresa Manresa, Barcelona, Spain
  • Corporació Sanitaria Parc Taulí Sabadell, Barcelona, Spain
View all 16 locations
View Trial Details
Completed

Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status

NCT04807595

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Research Site Pittsburgh, Pennsylvania, United States
  • Research Site Melbourne, Australia
  • Research Site Montreal, Quebec, Canada
  • Research Site Clermont-Ferrand, France
View all 13 locations
View Trial Details

Related conditions